The Moat Index
Compare moats, side by side.
Two to four companies, scored on the same five investor questions from their SEC filings — so the comparison is apples to apples. The method is fully public.
MTD · Healthcare · Wide moat
On the watchlist
The returnsOnCapital component abstained: Not enough years of ROIC data to score returns on capital. The other four 20% weights were renormalized over the scored 80%.
| Measure | MTD | INVA | HRMY | CPRX |
|---|---|---|---|---|
| Moat Score (0–100) | 82 (highest) | 82 (highest) | 82 (highest) | 82 (highest) |
| Methodology version | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 |
| Business trend | 72 | 45 | 95 (highest) | 95 (highest) |
| Pricing power | 97 | 98 | 99 | 100 (highest) |
| Returns on capital | — | 95 | 100 (highest) | 88 |
| Balance-sheet safety | 67 | 75 | 86 | 100 (highest) |
| Capital allocation | 91 | 100 (highest) | 32 | 24 |
| 186% above value if growth stopped today | 37% below value if growth stopped today (largest discount to value if growth stopped today) | 30% above value if growth stopped today | 234% above value if growth stopped today | |
| Market cap | $27.4B | $1.6B | $2.4B | $3.9B |
| Moat tier | Wide moat | Wide moat | Wide moat | Wide moat |
| Filing date | FY2025 | FY2025 | FY2025 | FY2025 |